report Invest in Basel region
Roivant wins the Tell Award (img: Bloomberg)

Roivant wins the Tell Award (img: Bloomberg)


Roivant Sciences recognized with Tell Award for its investment in Basel, Switzerland

The global healthcare company Roivant Sciences is a recipient of the 2017 Tell Award in recognition of its significant investment in Basel, Switzerland. The annual Tell Awards – named after the Swiss folk hero Wilhelm Tell - recognizes North American companies that have made substantial and innovative investments in Switzerland.

Roivant Sciences was nominated by the regional economic promotion agency for its commitment in the life sciences and innovation hub Basel. The biotech company opened its global headquarters in the city of Basel, Switzerland last year and plans to create 500 new jobs over the next 5 years. Basel’s top talent pool was one of the key drivers for Roivant Sciences to invest in the region.

The Award ceremony was held in conjunction with Bloomberg in New York on September 26th 2017 during the event “Inspiring Innovation”, which featured three panel discussions about the next generation of financial technologies driven by Artificial Intelligence (AI) and the blockchain technology. The Award was presented by Ambassador Andre Schaller, Consul General of Switzerland in New York.

Initiated by Switzerland Global Enterprise, the Tell Awards were established in 2004, and previous winners include Abbott, Biogen, Fossil, Sigma-Aldrich, Disney Research, Medtronic, Microsoft, eBay and Google.

In the picture above you see Daniel Bangser (Director North America, SGE), Sirpa Tsimal (, Gabriela Güntherodt (, Matthew Gline (CFO, Roivant Sciences), Brett Yacker (Senior Global Tax Counsel, Roivant Sciences), Andre Schaller (Ambassador and Consul General) and Patrik Wermelinger (Head Investment Promotion, SGE).

Roivant is creating a buzz in Basel Roivant Sciences, a fast-growing life sciences company from the US, recently opened its global headq...
Cookies uses cookies to ensure you get the best service on our website.
By continuing to browse the site, you are agreeing to the use of cookies.